The absence of satisfactory treatment options combined with the high risks for infants makes a compelling argument for aggressive protection against the disease in the U.S. through infant vaccination, along with the existing adolescent immunization strategy (to ensure continued immunity).

FORBES: Immunizing Bureaucrats Against Complacency